First Eagle中型股主動型ETF FEMD 深 滬
等待開盤 03-26 09:30:00 美东时间
34.0242
+0.334
+0.99%
華盛通- 最 高34.0242
- 今 開--
- 成交量 0股
- 最 低 34.0242
- 昨 收 33.6907
- 總市值 272.20万
- 52周最高 36.70
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 32.5281
- 委 比 0.00%
- 總股本 8.00万
- 歷史最高 36.70
- 量 比 0
- 振 幅 0.00%
- 歷史最低 32.5281
- 每 手 1
- 風險率 1.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer
BRIEF-LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer March 16 (Reuters) - LifeMD Inc LFMD.O : LIFEMD INC: ANNOUNCED APPOINTMENT OF ATUL KAVTHEKAR AS CHIEF FINANCIAL OFFICER Source text: ID:nGNXbPD7Fd Further company coverage: LFMD.O (( Reuters.Briefs@thomsonreuters.com
03-16 20:15
First Eagle's Active ETF Push Gathers Steam With New US Value Launches
First Eagle expands its active ETF lineup with two new U.S. value funds as ETF AUM hits $1.5 billion, building on strong early momentum.
01-29 04:18
BRIEF-LifeMd To Offer Market-Leading Pricing For Glp-1 Medications Wegovy And Ozempic In Continued Collaboration With Novo Nordisk
Nov 17 (Reuters) - LifeMD Inc LFMD.O: LIFEMD® TO OFFER MARKET-LEADING PRICING FOR GLP-1 MEDICATIONS WEGOVY® AND OZEMPIC® IN CONTINUED COLLABORATION WITH NOVO NORDISK LIFEMD INC - OFFERS GLP-1 MEDICATI...
2025-11-17 21:02
BRIEF-LifeMD Files Non-Timely 10-Q With US SEC
Nov 12 (Reuters) - LifeMD Inc LFMD.O: LIFEMD INC FILES NON-TIMELY 10-Q WITH U.S. SEC LIFEMD - IDENTIFIES ABOUT $4.6 MILLION IN CUMULATIVE OVER RECOGNITION OF REVENUE, WITH OFFSETTING AMOUNTS IN RELATE...
2025-11-13 06:22
BRIEF-LifeMD Expects To File Form 12B-25, Notifying US SEC Of Late Filing Of Form 10-Q For Period Ended September 30, 2025
Nov 5 (Reuters) - LifeMD Inc LFMD.O: LIFEMD INC - EXPECTS TO FILE FORM 12B-25, NOTIFYING U.S. SEC OF LATE FILING OF FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2025 Source text: ID:nGNX38bPS3 Further com...
2025-11-06 07:21
BRIEF-LifeMD Q4 Revenue USD 64.3 Million Versus. Ibes Estimate USD 57.4 Million
March 10 (Reuters) - LifeMD Inc LFMD.O: LIFEMD Q4 REVENUE USD 64.3 MILLION VERSUS. IBES ESTIMATE USD 57.4 MILLION LIFEMD Q4 NET INCOME USD -900 THOUSAND LIFEMD Q4 ADJUSTED EBITDA USD 9 MILLION VERSUS....
2025-03-11 05:31
